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Abstract 
Rationale: Inadequate monitoring of neuromuscular blockade (NMB) may result in worse patient 
outcomes, therefore NMB monitor availability is a minimum requirement for perioperative care 
according to the South African Society of Anaesthesiologists’ (SASA) 2018 Practice Guidelines. The 
authors performed an audit of peripheral nerve stimulators (PNS) functionality and availability at 
their institution. In the researcher’s experience the peripheral nerve stimulators (PNS) in use at 
his institution are not always easily available and some units malfunction at times. There are also 
not many units that can give a graphical display of a train of four ratio. This observation spurred 
the idea to do an audit on neuromuscular monitoring at this institution, by focusing on the 
availability and functionality of peripheral nerve stimulators. 
Methods: After ethics approval was obtained, an audit was performed. In order to assess function, 
the PNS were attached to an electrical circuit with a skin equivalent resistance. The resultant 
current impulses generated using Train-of-Four (TOF) mode and Double Burst Stimulation modes 
(DBS) were recorded with a voltage scope meter and visually assessed that the TOF was present 
and appeared equal. PNS availability was assessed in theatre and recovery areas against the SASA 
guideline standard of nerve stimulator availability. 
Results: Of the 65 PNS units assessed, 39 units were deemed to be dysfunctional and 26 units fully 
functional. The most frequent fault found (30 units) related to faulty or absent PNS electrode 
cables. Eight functional PNS units with TOF ratio display capability were found. The working PNS 
showed good inter-device peak voltage measurement correlation. Of the 59 areas identified 
where PNS should be easily available, only 37 areas met the PNS availability criteria suggested in 
the SASA guidelines. 
Discussion: This audit revealed that overall there were not enough functional PNS available at the 
institution, when measured against the SASA standard. The clinical significance of these findings 
would vary depending on the actual usage rate of NMBs in the area concerned. The logistics of 
tracking a PNS unit’s location also turns out to be paramount in situations where nerve stimulators 
have to be shared between areas. From a technical point of view, the working PNS were found to 
be very consistent in their delivered voltage bursts. Future use of the first generation PNS (without 
TOF ratio display) will continue to decline, because of their inability to monitor neuromuscular 
function by modern standards, and the poor availability of replacement parts for models no longer 
manufactured. The cost and availability of repairs and cable replacements should be factored into 
the decision when acquiring more PNS units. 
Conclusion: This audit highlighted the need for more new generation PNS with TOF-ratio-display- 
ability to align the institution with the recommendations from SASA standards and the anaesthetic 
literature. It also highlighted the accuracy and consistency of delivered current bursts by the 
working PNS devices. 
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Glossary of terms used: 
 
DBS - Double Burst Stimulation 
NMB - Neuromuscular blockade 
PACU – Post anaesthesia care unit 
PNS - Peripheral nerve stimulators 
PNS-zones – Areas where peripheral stimulator availability is needed according to South African 
Society of Anaesthesiologists’ practice guidelines 
PORC – Post-operative residual curarization 
POPC - Post-operative pulmonary complications 
RCWMCH – Red Cross War Memorial Children’s Hospital 
RNMB - Residual neuromuscular blockade 
SASA - South African Society of Anaesthesiologists 
TOF - Train-of-four peripheral nerve stimulator mode 
8 | P a g e  
PART A – STUDY PROTOCOL 
 
Introduction (study protocol) 
Monitoring of neuromuscular blockade (NMB) is considered to be a minimum requirement for 
providing an adequate standard of care in perioperative medicine and anaesthesia according to 
the South African Society of Anaesthesiologists’ (SASA) guidelines. 
The investigator previously found that some of the nerve stimulators in theatre did not seem to 
function reliably and that they were not always easily available in the theatres and recovery 
rooms. This observation sparked the idea to do an audit on neuromuscular monitoring at the 
hospitals staffed by the University of Cape Town’s Department of Anaesthesia and Perioperative 
Medicine, by focusing on the availability and functionality of our peripheral nerve stimulators. 
 
Background (study protocol) 
History of NMB monitoring 
 
The first muscle relaxant, d-tubocurarine, was introduced into anaesthetic practice in 1942 by 
Harold Griffith (Gillies & Wynands, 1985). As early as 1954, it was noted that patients who had 
received d-tubocurarine had a six fold higher mortality than patients who had not received the 
drug (Beecher & Todd, 1954). Use of a nerve stimulator to monitor the action of muscle relaxants 
was suggested in 1958. (Christie & Churchill-Davidson, 1958) 
 
Post-operative residual curarization (PORC) refers to the situation where skeletal muscle paralysis 
has not been adequately reversed at the end of anaesthesia. This was first recognized in the 1960’s 
in patients with renal function impairment where the clearance of NMB’s was reduced 
(Khirwadkar & Hunter, 2012). 
 
PORC was, in extreme cases, associated with mechanical respiratory failure due to respiratory 
muscle weakness. By 1971 it was suggested that the level of PORC could be assessed by using the 
train-of-four twitch technique (Ali, Utting & Gray, 1971). This involved the use of a peripheral 
nerve stimulator device to measure the ratio of the amplitudes of the fourth to the first twitch. A 
ratio of >0.7 was considered to indicate adequate recovery before endotracheal tube removal, 
given that it correlated well with the clinical parameters of head lift >5 seconds, hand grip 
strength, tongue protrusion and a vital capacity of >15ml/kg. This standard was used for many 
years thereafter. 
 
In 1997 (Berg et al., 1997) a significant post-operative pulmonary complication rate was reported 
if the train of four value was <0.7 in the immediate post-operative period after pancuronium 
administration. 
 
Around the same time it was demonstrated (Eriksson et al., 1997), using a small sample of 
volunteers, that pharyngeal tone approaches normal values when a concurrent train of four test 
(TOF), using the adductor pollicis muscle, demonstrates a ratio of more than 0.9. This cast doubt 
on the validity of the previously held threshold (a TOF ratio >0.7) being adequate for endotracheal 
tube removal. Subsequently a TOF ratio of >0.9 became the accepted standard to achieve before 
endotracheal tube removal (ETR). 
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In an editorial on PORC and evidence based medicine (Viby-Mogensen, 2000), it is stated that 
failure to antagonize vecuronium induced neuromuscular block will result in an unacceptably high 
incidence of patients with clinically significant PORC in the recovery room. It is also said that one 
cannot detect and confirm clinically significant PORC by tactile or visual assessment of peripheral 
nerve stimulation response. Even experienced observers cannot feel fade if the TOF ratio is above 
0.4 (Viby-Mogensen et al., 1985) (Saddler et al., 1990). Mechanomyography, electromyography 
and acceleromyography provides more objective assessment of PORC. (Viby-Mogenson, 2000) 
 
PORC has been associated with impaired respiratory physiology and an increase in post-operative 
complications, including: 
- Critical respiratory events in the post anaesthetic care unit. (Murphy, G. S. et al., 2008) 
o In this study 0.8% of patients developed critical respiratory events (61 of 7459 
patients). A subset (42) of the 61 patients were successfully matched with controls 
and analysed further. The most common complications found were hypoxaemia and 
upper airway obstruction. The TOF ratios, mean and (±standard deviation), in the 
critical respiratory event group were 0.62 (±0.2), and in the control patients the TOF 
ratios were 0.98 (±0.07). 
 
- Impaired respiratory muscle function (Kumar et al., 2012) 
o This study demonstrated a 21% reduction in forced vital capacity and a 19% reduction 
in peak expiratory flow rate in the early post-operative period in patients with residual 
neuromuscular blockade (RNMB) when compared to the patients who had no RNMB. 
These patients with RNMB received vecuronium, atracurium or rocuronium intra- 
operatively, and had a train-of-four-ratio of less than 0.9 at the time of testing. 
 
- Post-operative hypoxaemia (Sauer et al., 2011) 
o In this randomized prospective placebo controlled trial of 114 patients, patients 
received either neostigmine 20mcg/kg or placebo at the end of general anaesthesia 
that included rocuronium for neuromuscular blockade. Endotracheal tube removal 
was performed after no fade was detected on qualitative train-of-four stimulation and 
double-burst stimulation in the placebo group, and at a TOF ratio of 1.0 for the 
neostigmine group. Failure to reverse minimal PORC was associated with hypoxaemia 
in the post anaesthesia care unit (PACU), occurring about twice as often in the placebo 
group (29 occurrences) vs. the neostigmine group (16 occurrences) 
 
- Increased risk of post-operative pulmonary complication.(McLean et al., 2015) 
 
- Impaired clinical recovery (Murphy, G. S. et al., 2013) 
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In South Africa the following recommendations are made by the South African Society of 
Anaesthesiologists with regards to neuromuscular blockade monitoring and reversal (Kluyts et al., 
2018) 
- A peripheral nerve stimulator to monitor neuromuscular function is considered an essential 
item needed as a minimum requirement for the safe conduct of anaesthesia in any hospital. 
- Peripheral nerve stimulators should be immediately available in theatre and in the recovery 
room. 
- Patients should have recovered from neuromuscular blockade prior to handover to staff from 
the theatre recovery room, and thus also prior to discharge from the anaesthetist’s care. 
 
Methodology overview: 
 
Methodology 
 Study design 
o An audit of peripheral nerve stimulator (PNS) availability and function. 
o Comparison of our PNS equipment availability to the recommended standard. 
 Characteristics of the study population 
o No human subjects will be used 
 Recruitment and enrolment 
o No human subjects will be used 
 Location of the research 
o This audit will be performed at the following locations: Groote Schuur Hospital, Mowbray 
Maternity Hospital, Red Cross War Memorial Hospital, New Somerset Hospital, Maitland 
Cottage Hospital and Valkenberg Hospital. It may also be performed in the operating 
theatres, Technical Services workshop or departments of anaesthesia. It may also be 
performed in the Electrical Engineering laboratory on UCT upper campus. 
 Evaluator inclusion criteria 
o Evaluators need to be associated with the University of Cape Town or be current or past 
employees of the involved hospitals in one of the following roles: 
 Member of the Anaesthesia department, past or present as anaesthetists, or be 
 Employees of the Technical Support Services engineers at Groote Schuur Hospital 
or of the 
 Department of Electrical Engineering at the University of Cape Town 
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Research procedures and data collection methods 
 
Figure 1, Latest version of resistance circuit for PNS testing 
 
The study plan is to document the number of peripheral nerve stimulators that are available at 
the hospitals which are serviced by the Groote Schuur Hospital Department of Anaesthesia in the 
theatre and recovery areas. A unique identification number will be assigned to each nerve 
stimulator if they are not already labelled in such a way. Thereafter, the functionality of these PNS 
will be tested by confirming the presence of the electrical current bursts delivered during the TOF 
mode. 
 
In order to perform this measurement, the PNS will be connected to a skin-equivalent-resistance 
circuit e.g. in figure 1, and the voltage produced by the electrical current bursts set at 60 mA will 
be measured over the resistor. A test circuit resistance of between 1 and 4.5 kOhm is described in 
testing manuals. It is planned to utilise a 2.47 kOhm resistance setting. Thereafter a graphic display 
of the voltage/time wave loop of the TOF current burst will be recorded in electronic / 
photographic format. The PNS’s will be classified as either functional or faulty depending on the 
results of this test. The TOF peak voltage graph will be visually assessed for uniformness and 
deemed functional if the recorded voltage peaks appear equal in height. The voltage 
measurements will be recorded. A description of any faults found will also be documented. The 
type of faults found with specific brands of nerve stimulators may provide valuable information 
for the decision making process for future acquisitions of nerve stimulators. This procedure will 
then be repeated for each peripheral nerve stimulator tested. 
 
These findings will then be compared against the recommendation for PNS availability for 
neuromuscular monitoring from SASA to see if the recommended standard is met. 
 
Defining “adequate availability” requires some interpretation. For the purpose of this study, value 
will be placed on having a “known specific location” for the device.  If the device is kept in a 
specific labelled place just outside theatre, it will be defined as adequately available. On the other 
hand, if a unit is shared between multiple theatres and is not kept in a defined location within 
those theatres, it will be deemed “not easily available”. 
 
If availability of functional nerve stimulators falls short of the recommended standard, the number 
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of nerve stimulators needed and the areas of need will be identified and recorded. 
 
The results of this audit will form the basis for future annual audits. The audit findings will be made 
available to the clinical engineering workshops and clinical managers. 
In preliminary discussions with the technical team at Groote Schuur’s Clinical Engineering department, 
the investigator realised that the department of Clinical Engineering at Groote Schuur Hospital does not 
have access to a modern scope meter. Modern scope meters can accurately record, store and display 
the TOF recordings in a format that is downloadable for future reference. This is already an important 
finding for this audit. The investigator subsequently arranged with engineers from the UCT department 
of electrical engineering to utilise their scope meters and expertise in performing these audit 
recordings. 
 
Data safety and monitoring 
o The data will be stored on the principal and co-investigators’ computers and/or Dropbox 
accounts, which are password protected. 
Data analysis 
o Statistical analysis will be limited to analysis relevant to performing audits. 
o The tested peripheral nerve stimulators will be classified as functional or not. These 
evaluations will be recorded on an excel spreadsheet. 
o The data will be reported as proportions.  
 
 
 Describe mechanisms to ensure the accuracy and reliability of the data collected. 
A high quality scope meter with graphical display will be used. An engineer from the 
department of Electrical Engineering at the University of Cape Town (UCT) will be involved 
with the design of the skin resistance circuit board for the measurements taken. 
 
 
 
Description of risks and benefits 
 
There will be no risks to patients from the performance of this audit. A replacement PNS monitor will 
be made available in the relevant clinical areas from which PNS are removed while the devices are 
being tested. This precaution is taken to ensure PNS availability for clinical work within the areas 
audited. PNS that are discovered to be faulty on evaluation will be given to the theatre clinical 
technicians, who will see to the further evaluation and repair or replacement of the affected units. 
 
 
Potential benefits 
Ensuring that functioning PNS are available in all the relevant areas will likely increase their usage. This 
will lead to closer monitoring of, prevention and better treatment of, PORC (post-operative residual 
curarization). Prevention and treatment of PORC should result in improved patient morbidity and 
mortality. It could also prevent the psychological trauma that a patient with PORC may experience. 
 
 
The audit findings will be made available to the medical engineers and clinical managers. The data 
can then be used as the basis of an annual repetition of this audit. This will become a powerful tool, 
contributing to the process of keeping our fleet of PNS adequate in numbers and in a working 
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condition. 
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Informed consent process 
Informed consent is not needed from patients. 
 
 
Reimbursement for participation 
No reimbursement given 
 
 
Audit findings 
 
In total 59 “areas where a peripheral stimulator should be easily available” (PNS-zones) were 
identified. These areas consisted of 48 operating theatre or procedural areas (e.g. Catheterisation 
Laboratory, ECT Suite) and 11 recovery areas. 
Of these areas, 37 PNS-zones were deemed to meet the PNS availability criteria suggested in the SASA 
guidelines. When looking at the data in more detail, one would see that a PNS unit was found to be 
physically present in 21 areas, easily available in 19 areas and not easily available in 19 areas. The 3 
areas that resulted in the discrepancy between the 40 PNS-zones one would expect to be deemed 
appropriate and the 37 PNS-zones actually deemed appropriate are as follows: At a PNS-zone at 
RCWMCH a unit was found to be present and available in the Catheterisation Laboratory, but the 
battery was flat. The unit was thus available but overall it did not meet the SASA standard. Along the 
same lines, the PNS-unit found at Maitland Cottage hospital for both their theatre area and recovery 
area was available but faulty with severely corroded battery contact points (Neuromuscular blocking 
drugs are rarely used at this location for paediatric orthopaedic surgery). Those 3 areas were thus also 
deemed not to have a PNS available to the SASA standard. The 16 areas remaining included the 
following: No PNS unit was available at Valkenberg Hospital where anaesthesia for electro-convulsive 
therapy is performed. In the event of encountering a suxemethonium apnoea, a nerve stimulator 
would have to be borrowed from Groote Schuur Hospital which is 1.7km away. At Groote Schuur 
Hospital in the C6 Radiation Oncology theatre there was no PNS unit found, with the closest PNS unit 
found in the C8 interventional radiology suite (although this was not known in C6), or alternatively in 
the main theatre unit a couple of hundred metres away on a different floor level. At Groote Schuur 
Hospital a further five theatre blocks had one nerve stimulator per block, shared between multiple 
theatres but with no standardised base location. At Red Cross Hospital the trauma unit theatre and 
day case theatres on ground floor level did not have a PNS present, with the closest units available 
upstairs in the main theatre complex. 
As previously mentioned, defining “adequate availability” requires some interpretation. For the 
purpose of this study, value was placed on having a “known specific location” for the device and the 
perceived need for the device intra-operatively. If the device was kept in a specific labelled place just 
outside theatre, it would be defined as adequately available. On the other hand, if a unit was shared 
between 4 theatres and was kept in a random location somewhere in those theatres it was deemed 
“not easily available”. At RCWMCH 3 units were shared between 7 theatres, but with more units further 
away in the technicians’ office. The much lower usage of NDMR in the paediatric population compared 
to adult patients and the fact that the PNS-units were kept in well labelled locations, led us to believe 
that these PNS-zones were adequately covered. For argument sake, if the same ratio was found in a 
block of eye and neurosurgery theatres where most cases in each theatre would need PNMB 
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monitoring, we would have deemed those PNS-zones as “PNS not easily available.” 
In terms of testing individual devices, the aim was to find all the PNS units in clinical use and in the 
facilities’ storage areas. 65 PNS units were thus found and assessed. This included the units in the 
clinical areas, (but also the units found in the equipment rooms or clinical technicians rooms of the 
theatres as directed by the relevant technicians.) The different makes and models are depicted in the 
pie chart below. Of these assessed units 39 were deemed to be dysfunctional and the remaining 26 
units were deemed fully functional. 
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Figure 2: Summary of Audit results 
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Figure 3: PNS makes and models encountered 
 
 
Figure 4: Faults found with PNS 
Fisher&Paykel Innervator NS252 Lifetech Ezstim II ES400 
Fisher&Paykel Innervator NS252A Fisher&Paykel Innervator NS272 
Organon Technika Digistim 3 Plus GE E-NMT 
Xavant Stimpod NMS450 Organon TOF-watch 
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No electrode cables with unit 
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Batteries found to be flat 
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Number of units affected: 
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Figure 5:  Zone coverage further detailed (PNS = Peripheral nerve stimulator) 
The faults found with the units were as follows: 
- Absence of electrode cables was found in 27 units. These cables were either lost during clinical 
use, or discarded by technicians when they found the cables to be malfunctioning. Given that 
many of the units were no longer manufactured or supported by their manufacturers, these 
cables could no longer be ordered from them. 
Only 3 units were found to have faulty cables, but it may well be the most frequent 
malfunction found on the peripheral nerve stimulators, if one takes into account that a large 
portion of the “missing” cables may have originated with cable malfunction. 
- Physical damage was found in 23 of the units. The plastic housings of many units were 
fractured, presumably from dropping them on a hard surface during clinical use. The battery 
covers were missing from many units, which often resulted in unreliable contact between the 
batteries and electrodes. The batteries also tend to fall out easily in these scenarios, so many 
units were found with bits of sticky tape stuck on the unit in lieu of the battery cover to keep 
the batteries in place. 
- Two units would not switch on despite a change of batteries. 
- Batteries were found to be flat in 1 device in clinical use. 
- In one device the DBS button would not trigger a response. 
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The overall consistency of the delivered voltage spikes is noteworthy. In total 61 units were able to 
give scope meter recordings, although this was often performed with a set of “loan cables” where the 
units’ original cables were damaged or missing. This translated into 244 peak values for TOF voltage 
peak measurements. An assessment was made of the mean and standard deviation of the peak values 
measured with the scope meter.  In terms of this assessment all 61 the peak burst voltages of the first voltage 
impulse recorded was grouped together (PBV1), and likewise the groups of data thus classified for impulse 
groups 2, 3 and 4. The skewness and kurtosis suggested normal distribution of the data and there was 
no sign change from baseline readings with paired t-tests. 
 
Peak burst voltage Skewness Kurtosis Mean (Standard Deviation) 
PBV1 -0,906 0,163 144,79 (3,647) 
PBV2 -0,797 -0,29 144,66 (3,526) 
PBV3 -0,613 -0,39 144,64 (3,665) 
PBV4 -0,778 -0,138 144,59 (3,644) 
Table 1: Assessment of Peak Voltage Data (PBV = Peak burst voltage group) 
 
Data Pair Mean Standard deviation p- value 
Pair 1: PBV1 - PBV2 0,131 0,866 0,241 
Pair 2: PBV1 - PBV3 0,148 0,98 0,244 
Pair 3: PBV1 - PBV4 0,197 1,166 0,193 
Table 2: Data from paired samples test (PBV = Peak burst voltage group) 
 
In terms of the 7 units that did not deliver fully appropriate traces, the following is noted: Two Fisher 
and Paykel Innervator 252 units (labelled GSHPNS002 and GSHPNS003) gave “error 26” messages with 
no current bursts delivered. This error code was not listed with the units’ instruction manual. One 
Lifetech EZ stim unit (NSHPNS007) was found to have a faulty cable. Units that could not be switched 
on could obviously not provide test readings (including the units labelled GSHPNS011, MCHPNS001). 
In one unit the DBS button was broken and no DBS recording could be made (labelled GSHPNS012). In 
one unit the DBS pulse conduction was not reliable (labelled GSHPNS035). 
In a few units a current of 60mA could not be confirmed: One unit (labelled GSHPNS005) only had 
“level 1-8” on the current dial. At level 6&8 the voltages generated suggested currents in the ballpark 
of 60mA. In an older model Organon Technika Digistim 3 Plus (labelled GSHPNS038) the highest 
current setting was around 55 mA. 
TOF-ratio display capability was only represented in 14 of the units. Of these 14 units only 8 were fully 
functional. 
 
 
Discussion of results 
 
This audit revealed that overall there were not enough functional PNS available at the institution, 
when measured against the SASA standard. If you apply the highest standard, there were 8 functioning 
TOF-R capable peripheral nerve stimulators available to cover 59 areas. If we add the handheld devices 
without TOF-Ratio capability, 37 areas out of the 59 (63%) are covered. These assessments were in 
keeping with the author’s experience of PNS availability while working in clinical practice at this 
institution, where it was often difficult to locate a PNS at short notice. 
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The clinical significance of the shortage of PNS units varies depending on the actual need for PNMB 
monitoring in the area concerned. Despite this, the SASA practice guidelines do not make concessions 
for areas where PNS are less likely to be used and describe this as an essential monitor that needs to 
be immediately available. Thus, a lower likelihood of needing the device should not be used as an 
excuse for inadequate coverage. Despite the standard recommended by the SASA guidelines, for some 
hospitals the equipment budget may not lend itself to the purchasing of a PNS unit for each PNS-zone. 
In this real life financially constrained setting, it makes sense for theatre equipment managers to at 
least first ensure adequate PNS availability in the areas where it is most often needed while working 
towards adequate coverage. 
The logistics of tracking a PNS unit’s location is very important in situations where nerve stimulators 
have to be shared between locations. In areas where the nerve stimulator may be used in more than 
2 locations, immediate availability of the device is lost once it is in use. In order to facilitate locating 
the device, the unit has to be stored in a specific named “base” location, and the whereabouts of the 
device must be documented once it is removed. This could be with the use of a simple notebook kept 
at the “base location”, or by online systems such as a device location Whatsapp group shared between 
users of the device. 
From a technical point of view the working PNS were found to be very consistent in their delivered 
current bursts. This novel information is important when troubleshooting a peripheral neuromuscular 
monitoring unit. Looking at our data set there would be a high likelihood of the electrode cable being 
the problem. Another possible relevant factor that was not explored in this study is the likelihood of 
skin resistance contributing to measurement variance, since skin resistance may vary with skin 
thickness, moisture content and temporal association with prior electrical stimulation. It has also been 
known for a long time that skin impedance decreases when exposed to higher intensity currents. 
(Stephens, 1963) 
There are problems with the older PNS units, which comprise the majority of units in the institution: 
- The inability of these devices to exclude incomplete return of neuromuscular function by 
modern standards make them all but obsolete. However, some value remains in the ability to 
demonstrate very deep NMB levels where fade is detectable clinically and to demonstrate 
where a TOF count less than 4 is present. 
 
- The lack of manufacturer support for many of the first generation units in use at our institution 
shortens the foreseeable lifespan of the remaining functional units. Most of these units will 
become unusable at some point when they break down and need maintenance or repairs. 
Many of these PNS models are no longer manufactured. 
 
It can be inferred that it is unlikely that NMB monitoring is performed to the current accepted standard 
of a “TOF-R of > 0.9” if we have only 8 such devices available to cover 59 PNS zones at our institution. 
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Implications for the institution from the audit findings 
 
1. A modern scope meter with the ability to store and download test data in a downloadable 
format should be procured for the clinical engineering department, both to facilitate their day 
to day functioning, and also to assist future audit projects of electronic devices. 
 
2. At the time of this write-up a further 8 E-NMT units have already been delivered to GSH 
hospital, and the plan is to continue acquiring more TOF-R capable units as the budget allows. 
 
3. An awareness and educational campaign needs to be launched within the department of 
anaesthesia to educate and motivate anaesthetists to: 
 
a. Utilize appropriate NMB monitoring, and 
b. Advocate for the provision of adequate numbers of PNS-devices. 
 
4. The cost and availability of repairs and cable replacements should be factored into the 
decision when acquiring more PNS units. The machine mounted PNS units retail for more than 
3 times the price of the handheld devices. It is hypothesized that the machine mounted units 
may last longer due to: 
o Higher quality electrode cabling 
o Less handling of the machine mounted units, resulting in 
 A smaller chance of being dropped and broken 
 Less winding up / coiling of the electrode cables which may prolong cable life. 
 
5. The cost-benefit ratio of these two current options (E-NMT vs. Xavant Stimpod NMS450) 
should be further audited while in use to help guide future acquisitions of these devices. 
 
 
Audit conclusion: 
 
This audit highlighted the need for more new generation PNS with TOF-ratio-display-ability at the 
hospitals staffed by the department of Anaesthesia and Perioperative Medicine at the University of 
Cape Town, to be aligned with the recommendations from the anaesthetic literature. It also 
highlighted the need for an improved sharing system in those areas were PNS: clinical area ratio is <1. 
This research also highlighted the accuracy and consistency of delivered current bursts by the working 
PNS devices. There are opportunities for further research in evaluating the contribution of skin related 
factors on the conduction of current bursts with PNS’s. 
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PART B - STRUCTURED LITERATURE REVIEW: 
 
Introduction and objectives (literature review) 
Monitoring of neuromuscular blockade (NMB) is considered to be a minimum requirement for 
providing an adequate standard of care in perioperative medicine and anaesthesia according to 
the South African Society of Anaesthesiologists’ (SASA) guidelines. 
The investigator previously found that some of the nerve stimulators in theatre did not seem to 
function reliably and that they were not always easily available in the theatres and recovery 
rooms. This observation spurred the idea to do an audit on neuromuscular monitoring at the 
hospitals staffed by the University of Cape Town’s department of anaesthesia, by focusing on the 
availability and functionality of our peripheral nerve stimulators. 
This literature review aims to highlight the evidence base for the current guidelines on 
neuromuscular monitoring as published by SASA. The investigators did not come across any similar 
audits during their literature search. 
 
 
 
 
Literature search strategy 
 
The literature search was performed using 3 databases, namely PubMed, Scopus and Africawide. The 
search results were limited to English and Afrikaans studies and animal studies were also excluded. A 
number of further exclusion keywords were added to the search terms to limit the amount of 
irrelevant material generated, which was identified in trial runs of the search. 
The particular terms used were as follows: 
((((((((((((((((Postoperative residual curarization[Title] OR postoperative neuromuscular 
blockade[Title]) OR postoperative neuromuscular function[Title]) OR Residual paralysis[Title]) OR 
Partial paralysis[Title]) OR Partial neuromuscular block[Title]) OR (Reversal[All Fields] AND 
neuromuscular blockade[Title])) OR (Peripheral[All Fields] AND neuromuscular monitor[Title])) OR 
Peripheral nerve stimulator[Title]) OR TOF ratio[Title]) OR Train of four[Title]) OR Double burst 
stimulation[Title]) NOT deep brain stimulation[Title/Abstract]) NOT Myasthenia[Title]) NOT 
Infection[Title]) NOT Blood[Title]) NOT Leucocyte[Title]) NOT Intoxication [Title] 
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Figure 6: Screenshots demonstrating search terms on PubMed, Scopus and Africawide 
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From the initial search results, journal titles were screened and accepted or discarded depending on 
the perceived relevance from the journal title. The accepted/selected articles were further 
investigated for their relevance in contributing to the body of knowledge regarding Post-operative 
residual curarization (PORC) and peripheral nerve stimulator use. In the PubMed search the initial 
search produced more than 4600 hits. From these 152 articles were thought to have some relevance 
to the literature review topic and 26 review articles were found with some relevance to the research 
topic. From the Scopus database search 205 articles was identified with some relevance to the 
research topic. In the Africawide search 8 articles with some relevance to the research topic were 
found. Whilst reading through some of the journal articles found, further articles of relevance were 
identified from the article’s reference lists and those were further evaluated as was deemed 
necessary. In the final publication-ready article produced, 30 of these sources found were used as 
references. Of note, the investigators did not come across any similar audits during their literatures 
search.  
 
 
Background (literature review) 
History and practice of NMB monitoring 
 
The first muscle relaxant, d-tubocurarine, was introduced into anaesthetic practice in 1942 by 
Harold Griffith (Gillies & Wynands, 1985). As early as 1954, it was noted that patients who had 
received d-tubocurarine had a six fold higher mortality than patients who had not received the 
drug (Beecher & Todd, 1954). 
 
The situation where skeletal muscle paralysis has not been adequately reversed at the end of 
anaesthesia has been described as post-operative residual curarization (PORC). 
This was first recognized in the 1960’s in patients with renal function impairment where the 
clearance of NMB’s was reduced. (Khirwadkar & Hunter, 2012) 
 
In 1958 the use of a nerve stimulator to monitor the action of muscle relaxants was suggested 
(Christie & Churchill-Davidson, 1958), but for many years thereafter only clinical parameters were 
used to infer the absence of clinically significant PORC in the recovery area, including: 
- Head lift more than 5 seconds 
- Tongue protrusion 
- Vital capacity >15ml/kg (Brand et al., 1977) 
- Hand grip strength (Russell & Serle, 1987); 
 
PORC was, in extreme cases, associated with mechanical respiratory failure due to respiratory muscle 
weakness. By 1971 it was suggested that the level of PORC could be assessed by using the train-of- 
four twitch technique (TOF) (Ali, Utting & Gray, 1971). This involved the use of a peripheral nerve 
stimulator device (PNS) to measure the ratio of the amplitudes of the fourth to the first twitch. A ratio 
of >0.7 was considered to indicate adequate recovery before endotracheal tube removal, given that it 
correlated well with the clinical parameters of head lift for more than 5 seconds, hand grip strength, 
tongue protrusion and a vital capacity of more than 15ml/kg. This standard was used for many years 
thereafter. Years later (Berg et al., 1997) a significant post-operative pulmonary complication rate was 
reported if the train of four value was <0.7 in the immediate post-operative period after pancuronium 
administration. 
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Around the same time it was demonstrated (Eriksson et al., 1997), using a small sample of volunteers, 
that pharyngeal tone approaches normal values when a concurrent train of four test (TOF) of the 
adductor pollicis muscle demonstrates a ratio of more than 0.9. This cast doubt on the validity of the 
previously held threshold of a TOF ratio > 0.7 being adequate for endotracheal tube removal. 
Subsequently a TOF ratio of > 0.9 became the accepted standard to achieve before endotracheal tube 
removal (ETR). 
Another concern is related to the inability to detect fade by clinical examination during TOF delivery. 
It is said that one cannot detect and confirm clinically significant PORC by tactile or visual assessment 
of the peripheral nerve stimulation response. Even experienced observers cannot feel fade if the TOF 
ratio is above 0.4 (Viby-Mogensen et al., 1985) (Saddler et al., 1990). Mechanomyography, 
electromyography and acceleromyography are alternative measurement techniques that provide 
more objective assessments of PORC. (Viby-Mogenson, 2000) 
Recent studies have shown that the TOF ratio is slightly overestimated when it is determined using 
acceleromyography. Thus it is questioned whether a TOF ratio of 1.0 should rather be aimed for in 
order to infer an effective TOF ratio more than 0.9. (Capron et al., 2004, Kopman, A. F., Klewicka & 
Neuman, 2002) 
 
Clinical significance 
 
It is well described in the literature that PORC leads to increased post-operative complications, 
including: 
- Airway and breathing compromise 
- An unpleasant patient experience (Murphy, G. S. et al., 2013) (Murphy, Glenn S et al., 2003) 
and 
- Decreased theatre efficiency 
 
In the South African context two studies reported incidences of 29% and 43% respectively for PORC 
with TOF <0.9. (Invernizzi & Gopalan, 2016, Nell et al., 2004) Elsewhere a meta-analysis in 2007 
inferred that PORC is common, with an estimated TOF < 0.9 incidence rate of about 41% in patients 
who received intermediate acting NMB’s. (Naguib, Kopman & Ensor, 2007) 
Airway and breathing compromise: 
 
- Increased episodes of aspiration are described. A five times higher rate of laryngeal 
penetration was described in a study of healthy volunteers with partial neuromuscular 
paralysis given an infusion of atracurium with concomitant monitoring of the TOF ratio and 
video radiography of the larynx during swallowing. (Sundman et al., 2000) 
 
- PORC is associated with an increased risk of post-operative pulmonary complications (POPC), 
defined as: respiratory failure, pulmonary oedema, tracheal re-intubation and pneumonia. 
Data from a retrospective analysis of hospital records of 48499 patients showed an association 
between higher doses of neuromuscular blocking drugs and POPC. (McLean et al., 2015) 
 
 
- More episodes of upper airway obstruction during transport to the PACU were observed in 
patients managed with conventional qualitative TOF assessment compared to similar patients 
managed with acceleromyographic quantitative TOF monitoring. This data was from a study 
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of 179 patients, comparing the ability of qualitative and quantitative assessment of 
neuromuscular function to help detect (and indirectly reduce) the occurrence of PORC after 
endotracheal tube removal. In the conventional TOF group the mean TOF ratio was lower 
when checked in PACU for the study. It was found that 0% of patients in the 
acceleromyographic group needed manoeuvres to open their airway during transport to 
PACU, compared with 11% of patients in the conventional TOF group. (Murphy, Glenn S et al., 
2008) 
 
- Post-operative hypoxaemia (Sauer et al., 2011). In this randomized prospective placebo 
controlled trial of 114 patients, patients received either neostigmine 20 mcg/kg or placebo at 
the end of general anaesthesia that included rocuronium for neuromuscular blockade. 
Endotracheal tube removal was performed after no fade was detected on qualitative train-of- 
four stimulation and double-burst stimulation in the placebo group, and at a TOF ratio of 1.0 
for the neostigmine group. Failure to reverse minimal PORC was associated with hypoxaemia 
in the post anaesthesia care unit (PACU), occurring about twice as often in the no-neostigmine 
placebo group (29 occurrences) vs. the neostigmine group (16 occurrences) 
 
- Critical respiratory events in the post anaesthetic care unit (Murphy, G. S. et al., 2008). In this 
study 0.8% of patients developed critical respiratory events (61 of 7459 patients). A subset 
(42) of the 61 patients were successfully matched with controls and analysed further. The 
most common complications found were hypoxaemia and upper airway obstruction. The TOF 
ratios, mean and (±standard deviation), in the critical respiratory event group were 0.62 
(±0.2), and in the control patients the TOF ratios were 0.98 (±0.07). 
 
- Impaired respiratory muscle function (Kumar et al., 2012). This study demonstrated a 21% 
reduction in forced vital capacity and a 19% reduction in peak expiratory flow rate in the early 
post-operative period in patients with residual neuromuscular blockade (RNMB) when 
compared to the patients who had no RNMB. These patients with RNMB received vecuronium, 
atracurium or rocuronium intra-operatively, and had a train-of-four-ratio of less than 0.9 at 
the time of testing. 
 
 
An unpleasant experience: 
 
- In one study, 149 patients arriving in PACU were divided into two groups based on a measured 
TOF ratio of < 0.9 and ≥ 0.9 respectively. (Murphy, G. S. et al., 2013) The 48 patients who fell 
in the TOF ratio < 0.9 group were found to have, after arrival in PACU: 
 A feeling of general muscle weakness in 73% at 60 min 
 Inability to swallow in 29% at 20min 
 Inability to speak normally in 33% of patients at 40 min 
 Inability to cough normally in 27% at 40 min 
 Inability to breathe deeply in 15% of patients at 40 min 
 Blurry vision in 23% and diplopia in 10% at 60 min 
 Inability to perform a 5-second head lift in 58% at 20 min 
 Inability to perform a sustained 5 second hand grip in 21% at 20 min and in 
6% at 40 min 
 Inability to perform a 5 second tongue protrusion in 5% of patients at 40min 
It is no surprise that some of these symptoms associated with PORC are reported as unpleasant. 
(Kopman, Aaron F, Yee & Neuman, 1997) 
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Decreased perioperative efficiency 
 
Longer time to discharge from the Post Anaesthetic Care Unit (PACU) has been described for patients 
with PORC (Butterly et al., 2010) In this study of 246 consecutive PACU patient admissions, the average 
time in PACU was 243min for patients with adequate recovery compared to 323 minutes for patients 
who had a TOF ratio of <0.9. 
Slower postoperative weaning from ventilation and longer times to endotracheal tube removal have 
been associated with lower TOF ratios after cardiac surgery. (Murphy, Glenn S et al., 2003) This 
prospective randomized double blinded trial studied the recovery of neuromuscular function in two 
patient groups who received either rocuronium or pancuronium. An association was demonstrated 
between lower TOF ratios, slower ventilator support withdrawal and longer times to removal of 
endotracheal tubes. 
 
 
Why do some anaesthetists monitor NMB inadequately? 
 
At the authors’ institution, the perceived lack of availability of PNS could contribute to inadequate 
monitoring and management of neuromuscular blockade. This encouraged the authors to perform 
an audit of PNS. 
Worldwide it is described that many anaesthetists are still not monitoring the level of 
neuromuscular blockade with a quantitative modality such as the TOF ratio. Hypothesis as to why 
that may be, include:(Brull & Prielipp, 2015) 
- Heuristics: Clinician behaviour may be affected by heuristics. Heuristics are educated mental 
guesses or shortcuts made based on pattern recognition from prior clinical experience e.g. 
“Vecuronium blockade can always be reversed an hour after intubation”. This pattern of 
thinking may lead to: 
- Confirmation bias, which involves accepting subjective data as supportive of a desired 
outcome e.g. “a strong hand grip” to confirm the anticipated lack of PORC after reversal with 
neostigmine. This confirmation bias often contributes to and compounds an existing 
“anchoring bias”, e.g. “All my cases do well in PACU since I am a great anaesthetist with 
expertise and experience” 
- Production pressure to optimize turnaround time between surgical operating time, in 
combination with 
- Complacency bred from past “successes”. These past “successes” (partially explained by the 
low incidence of attribution of significant post-op morbidity to inadequate neuromuscular 
reversal) breed a delusional complacency. This can be followed by disbelief and confusion 
when urgent endotracheal tube reinsertion is required shortly after arrival in PACU. 
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Summary of the literature: 
What should anaesthetists be doing? 
 
In South Africa the following recommendations are made with regards to neuromuscular blockade 
monitoring and reversal (Kluyts et al., 2018) (South African Society of Anaesthesiologists [SASA] 2018): 
- A peripheral nerve stimulator to monitor neuromuscular function is considered an essential 
item needed as a minimum requirement for the safe conduct of anaesthesia in any hospital. 
- Peripheral nerve stimulators should be immediately available in theatre and in the recovery 
room. 
- Patients should have recovered from neuromuscular blockade prior to handover to staff from 
the theatre recovery room, and thus also prior to discharge from the anaesthetist’s care. 
 
 
It is well described in the literature that PORC leads to increased post-operative complications, 
including: 
- Airway and breathing compromise 
- An unpleasant patient experience (Murphy, G. S. et al., 2013) (Murphy, Glenn S et al., 2003) 
and 
- Decreased theatre efficiency 
 
It is now widely accepted that patients should have their neuromuscular function monitored peri- 
operatively during and after the administration of neuromuscular blocking agents until full return of 
neuromuscular function, and that failure to antagonize neuromuscular block may result in an 
unacceptably high incidence of patients with clinically significant PORC in the recovery room.(Viby- 
Mogensen, 2000) 
It is also described in the literature that PORC cannot be assessed adequately without an objective 
measure of neuromuscular function (Saddler et al., 1990, Viby-Mogensen et al., 1985). Taken in 
conjunction with the SASA recommendations above, it is the author’s opinion that neuromuscular 
function should be assessed using a PNS device with TOF ratio display capabilities whenever possible. 
Older style PNS devices without TOF ratio display capabilities should thus only be used if no better 
devices are available. 
Reversal agents should be administered appropriately, using quantitative TOF ratio evidence to guide 
the need for its administration, i.e. reversal agents to be administered if the TOF ratio is <0.9. 
 
 
When TOF ratio capable devices are not available 
 
In the situation where TOF ratio capable devices are not available and older generation PNS are used, 
the following is recommended (Thilen & Bhananker, 2016): 
- Start monitoring early, before administration of NMB drugs. This way technical errors such as 
faulty cables are excluded, and a baseline reference TOF twitch is obtained. 
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- Reduce follow up doses of PNMB drugs for outliers who are found to take longer to recover 
after their initial dose of PNMB 
- Be conscious of the variation between different sites of PNMB monitoring 
o The Ulnar nerve/adductor pollicis site is the preferred site for monitoring, 
o Posterior tibial nerve/ great toe function recovers quicker after NMB, thus assessment 
here underestimates residual NMB. 
o Facial nerve/eye muscle site monitoring has been shown to be unreliable with a 
heightened incidence of PORC if it is used to guide neostigmine therapy. 
- Avoid unnecessarily deep NMB. For many procedures, e.g. lower abdominal surgeries, a block 
depth with TOF count 1 to 2 is usually appropriate. 
- Confirm an adequate level of spontaneous recovery prior to giving neostigmine. 
o Ideally a TOF count of 4 should be present before neostigmine administration, rather 
than the TOF count of >1 mentioned in older guidelines. 
o If spontaneous recovery has occurred to the point where no fade on TOF stimulation 
can be palpated, then the neostigmine dose given should not exceed 20 – 25 mcg/kg 
- One should err on giving rather than not giving neostigmine reversal, given that the 
complications of PORC outweighs the theoretical risks of short-lived paradoxical weakness 
with reversal of NMB agents in patients with high TOF ratios. (Murphy, G S & Kopman, 2016) 
 
 
 
The elderly patient 
 
Slower clearance and altered pharmacokinetics of neuromuscular blockers play a significant role in 
the higher observed incidence of PORC in patients older than 65 years. This effect is more pronounced 
with the aminosteroids, but is also described to a lesser extent with the benzylisoquinoline class of 
neuromuscular blockers. Pharmacodynamics are much less affected but some dose reductions may 
still be needed. Therefore, the monitoring of neuromuscular blockade in the elderly should be 
routinely performed with TOF ratio display capable monitoring to ensure that a TOF ratio > 0.9 is 
achieved at the end of anaesthesia. (Stankiewicz-Rudnicki, 2016) 
 
 
Looking to the future 
 
Novel drugs may influence the long term management of neuromuscular blockade perioperatively. 
Sugammadex can rapidly reverse even deep neuromuscular blockade by encapsulating aminosteroids 
i.e. rocuronium and also vecuronium (Paton et al., 2010). However, its high cost prohibits routine use 
for reversal in South Africa. 
Cysteine may become a PNMB reversal drug if/when gantacurium is released for routine use in 
anaesthetic practice (de Boer & Carlos, 2018). Gantacurium is an isoquinolinium diester derivative of 
chlorofumaric acid which closely mimics the onset and offset of patterns of succinylcholine. The quick 
offset of gantacurium stems from cysteine adduction induced chemical degradation. Degradation by 
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pH-sensitive hydrolysis also contributes to the metabolism as a slower process. Reversal of PNMB 
induced by gantacurium can also be performed with edrophonium administration. 
Calabadion is a novel reversal agent that can encapsulate both aminosteroid and benzylisoquinolinium 
NMBD’s with a greater affinity for these drugs than sugammadex. (De Boer & Carlos, 2018) 
While these novel agents that rapidly reverse neuromuscular blockade will likely decrease the 
incidence of PORC, the requirement to monitor intra-operative neuro-muscular function will remain, 
especially for operations such as retinal eye surgery and brain surgery, where prevention of sudden 
movement or coughing will remain crucial. 
 
 
Further research opportunities: 
 
There are opportunities for further research in evaluating the contribution and effect of skin related 
factors on the measurement of residual paralysis with peripheral nerve stimulators. TOF 
measurements may theoretically be influenced by the properties of the skin itself, since skin resistance 
may vary with skin thickness, moisture content and temporal association with prior electrical 
stimulation. It has also been known for a long time that skin impedance decreases when exposed to 
higher intensity currents. (Stephens, 1963) 
Research opportunities exist to identify the most important barriers to appropriate neuromuscular 
blockade monitoring in South Africa. If anaesthetists in well-resourced settings are not monitoring 
PNMB adequately, one can assume that monitoring is inadequate in more resource-constrained 
settings. Investigating these factors would provide insight on how to direct our limited resources in 
South Africa to best address the problems encountered. 
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Abstract 
Background: Inadequate monitoring of neuromuscular blockade (NMB) may result in worse patient 
outcomes, therefore NMB monitor availability is a minimum requirement for perioperative care 
according to the South African Society of Anaesthesiologists’ (SASA) 2018 guidelines. The authors 
performed an audit of peripheral nerve stimulators (PNS) functionality and availability at their 
institution. 
Methods: The PNS were attached to an electrical circuit with a skin equivalent resistance. The 
resultant current impulses generated using Train-of-Four (TOF) mode and Double Burst 
Stimulation modes were recorded with a voltage scope meter. PNS availability was assessed in 
theatre and recovery areas. 
Results: Of the 65 PNS units assessed, 39 units were deemed to be dysfunctional and 26 units fully 
functional. The most frequent fault found (30 units) related to faulty or absent PNS electrode cables. 
Eight functional PNS units with TOF ratio display capability was found. The working PNS showed 
good inter-device peak voltage measurement correlation. Of the 59 areas identified where PNS 
should be easily available, only 37 areas met the PNS availability criteria suggested in the SASA 
guidelines. 
Conclusion: This audit highlighted the need for more new generation PNS with TOF-ratio-display- 
ability to align the institution with the recommendations from SASA standards and the anaesthetic 
literature. It also highlighted the accuracy and consistency of delivered current bursts by the 
working PNS devices. 
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Introduction 
History and practice of NMB monitoring 
 
The first muscle relaxant, d-tubocurarine, was introduced into anaesthetic practice in 1942 by 
Harold Griffith1. As early as 1954, it was noted that patients who had received d-tubocurarine had 
a six fold higher mortality than patients who had not received the drug2. The situation where skeletal 
muscle paralysis has not been adequately reversed at the end of anaesthesia has been described as 
post-operative residual curarization (PORC). This was first recognized in the 1960’s in patients 
with renal function impairment where the clearance of NMB’s was reduced.3 In 1958 the use of a 
nerve stimulator to monitor the action of muscle relaxants was suggested4, but for many years 
thereafter only clinical parameters were used to infer the absence of clinically significant PORC in 
the recovery area, including: 
-  Head lift more than 5 seconds 
- Tongue protrusion 
- Vital capacity >15ml/kg 5 
- Hand grip strength 6; 
 
PORC was, in extreme cases, associated with respiratory failure due to respiratory muscle 
weakness. By 1971 it was suggested that the level of PORC could be assessed by using the train- 
of-four twitch technique (TOF).7 This involved the use of a peripheral nerve stimulator (PNS) to 
measure the ratio of the amplitudes of the fourth to the first twitch. A ratio of > 0.7 was considered 
to indicate adequate recovery before endotracheal tube removal, given that it correlated well with 
the clinical parameters mentioned above. This standard was used for many years thereafter. In 1997 
8 a significant post-operative pulmonary complication rate was reported if the train of four value 
was <0.7 in the immediate post-operative period after pancuronium administration. 
 
Around the same time it was demonstrated 9 (by TOF-testing the adductor pollicis muscles of a 
small sample of volunteers) that pharyngeal tone approaches normal values when the concurrent 
TOF demonstrates a ratio of more than 0.9. This cast doubt on the validity of the previously held 
threshold being adequate for endotracheal tube removal. Subsequently a TOF ratio of >0.9 became 
the accepted standard to achieve before endotracheal tube removal. 
 
Another concern is related to the inability to detect fade by clinical examination during TOF 
delivery. It is said that one cannot detect and confirm clinically significant PORC by tactile or visual 
assessment of the peripheral nerve stimulation response. Even experienced observers cannot feel 
fade if the TOF ratio is above 0.4 10, 11. Mechanomyography, electromyography and 
acceleromyography are alternative measurement techniques that provide more objective 
assessments of PORC. 12 
 
Recent studies have shown that the TOF ratio is slightly overestimated when it is determined using 
acceleromyography. Thus it is questioned whether a TOF ratio of 1.0 should rather be aimed for 
when acceleromyography is used, in order to ensure a TOF ratio above 0.9. 13, 14 
 
Clinical significance 
 
It is well described in the literature that PORC leads to increased post-operative complications, 
including: 
- Airway and breathing compromise 
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- An unpleasant patient experience 15 16 and 
- Decreased theatre efficiency 
 
In the South African context two studies reported incidences of 29% and 43% respectively for 
PORC with TOF <0.9. 17, 18 Elsewhere a meta-analysis in 2007 infer that PORC is common, with 
an estimated TOF < 0.9 incidence rate of about 41%, in patients who received intermediate acting 
NMB’s. 19 
 
Airway and breathing compromise: 
 
- A five times higher rate of aspiration (laryngeal penetration) was described in a study of 
partially paralysed healthy volunteers given an infusion of atracurium with concomitant 
monitoring of the TOF ratio and video radiography of the larynx. 20 
 
- PORC is associated with an increased risk of post-operative pulmonary complications (POPC), 
defined as: respiratory failure, pulmonary oedema, tracheal reintubation and pneumonia. Data 
from a retrospective analysis of hospital records of 48499 patients showed an association 
between higher doses of neuromuscular blocking drugs and POPC. 21 
 
- More episodes of upper airway obstruction during transport to the PACU were observed in 
patients managed with conventional qualitative TOF assessment compared to similar patients 
managed with acceleromyographic quantitative TOF monitoring. 22 
 
- Post-operative hypoxaemia 23 
o In this randomized prospective placebo controlled trial of 114 patients, patients 
received either neostigmine 20mcg/kg or placebo at the end of general anaesthesia that 
included Rocuronium for neuromuscular blockade. Failure to reverse minimal PORC 
was associated with hypoxaemia in the post anaesthesia care unit (PACU), occurring 
about twice as often in the no-neostigmine placebo group (29 occurrences) vs. the 
neostigmine group (16 occurrences) 
 
- Critical respiratory events in the post anaesthetic care unit. 24 
o In this study 0.8% of patients developed critical respiratory events (61 of 7459 
patients). The most common complications found were hypoxaemia and upper airway 
obstruction. The TOF ratios, mean and (±standard deviation), in the critical respiratory 
event group were 0.62 (±0.2). 
 
 
An unpleasant experience: 
 
- In one study, 149 patients arriving in PACU were divided into two groups based on a measured 
TOF ratio of < 0.9 and ≥ 0.9 respectively. The 48 patients who fell in the TOF ratio < 0.9 group 
were found to have, after arrival in PACU: 
 A feeling of general muscle weakness in 73% at 60min 
 Inability to swallow in 29% at 20min 
 Inability to speak normally in 33% of patients at 40min 
 Inability to cough normally in 27% at 40min 
 Inability to breathe deeply in 15% of patients at 40min 
 Blurry vision in 23% and diplopia in 10% at 60min 
It is no surprise that some of these symptoms associated with PORC are reported as unpleasant. 25 
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Decreased perioperative efficiency 
 
Longer times to discharge from the Post Anaesthetic Care Unit (PACU) has been described for patients 
with PORC 26 In this study of 246 consecutive PACU patient admissions, the average time in PACU 
was 243min for patients with adequate recovery compared to 323 minutes for patients who had a TOF 
ratio of <0.9. 
Slower postoperative weaning from ventilation and longer times to endotracheal tube removal has been 
associated with lower TOF ratios after cardiac surgery. 16 
 
 
Why do some anaesthetists monitor NMB inadequately? 
 
At the authors’ institution, the perceived lack of availability of PNS could contribute to inadequate 
monitoring and management of neuromuscular blockade. This encouraged the authors to perform 
an audit of PNS. 
Worldwide it is described that many anaesthetists are still not monitoring the level of neuromuscular 
blockade with a quantitative modality such as the TOF ratio. Hypothesis as to why that may be, 
include:27 
- Heuristics, 
- Confirmation bias, 
- Production pressure to optimise turnaround time and 
- Complacency bred from past “successes”. 
 
What should anaesthetists be doing? 
 
In South Africa the following recommendations are made with regards to neuromuscular blockade 
monitoring and reversal 28 (South African Society of Anaesthesiologists [SASA] 2018): 
- A peripheral nerve stimulator to monitor neuromuscular function is considered an essential item 
needed as a minimum requirement for the safe conduct of anaesthesia in any hospital. 
- Peripheral nerve stimulators should be immediately available in theatre and in the recovery 
room. 
- Patients should have recovered from neuromuscular blockade prior to handover to staff from 
the theatre recovery room, and thus also prior to discharge from the anaesthetists care. 
It is described in the literature that PORC cannot be assessed adequately without an objective measure 
of neuromuscular function 10, 11. Taken in conjunction with the SASA recommendations above, it is the 
author’s opinion that neuromuscular function should be assessed using a PNS device with TOF ratio 
display capabilities. 
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Methodology 
 
Overview 
o The study was designed as an audit of PNS availability and function with the aim to compare 
our PNS equipment availability to the recommended standard. More than 90% of data 
collection was done between 2 January 2018 and 2 February 2018, and the last area was 
assessed on 15 May 2018. Ethics approval was obtained from the University of Cape Town, 
Faculty of Health Sciences Human Research Ethics Committee, HREC REF: 771/2017 
 Study location 
o This audit was performed at the hospitals staffed by the department of Anaesthesia and 
Perioperative Medicine at the University of Cape Town, which included the following 
locations: Groote Schuur Hospital, Mowbray Maternity Hospital, Red Cross War Memorial 
Children’s Hospital, New Somerset Hospital, Maitland Cottage Hospital and Valkenberg 
Hospital (hereafter referred to as “the authors’ institution”.) 
 Research procedures and data collection methods 
The number of PNS available in the theatre and recovery areas of the institution were documented. 
These findings were judged against the 2012 SASA practice guidelines. A unique identification 
number was assigned to each PNS unit. Thereafter, the functionality of these units was tested by 
confirming the presence of the electrical current bursts delivered during the TOF and double burst 
stimulation (DBS) modes. In order to perform these measurements, the PNS were connected to a 
skin-equivalent-resistance circuit built by the co-author Mr Pead. (See Figure 1) 
 
 
 
 
Figure 1: Latest version of resistance circuit for PNS testing 
 
. 
41 | P a g e  
It was opted to use a 2.47kOhm resistor for this, given that between 1 and 4.5 kOhm is described in 
test manuals. The voltage produced by the electrical current bursts set at 60mA were measured over 
the resistor. Thereafter a graphic display of the voltage/time wave loop of the TOF and DBS current 
bursts were recorded in numerical (Excel®) and digital photographic (PNG file) format using a 
Keysight InfiniiVision EDUX1002G Digital Storage Oscilloscope. The PNS were classified as either 
functional or faulty depending on the results of this test, applying Ohm’s law. Data were recorded 
by Dr. Joubert and stored on a password-protected Excel spreadsheet. 
 
Statistics 
Complex statistical analysis was not needed. The nerve stimulators were classified as functional or not, 
and the nature of the faults described. The areas assessed for PNS availability were classified into three 
groups with PNS either “physically present”, “easily available” or “not easily available.” 
Given the striking repeatability of the PNS recordings between devices, it was opted to use descriptive 
statistical analysis of this data to demonstrate and emphasize this finding using the mean and standard 
deviation, once it was confirmed that the data was normally distributed. 
 
 
 
Results: 
 
In total 59 areas where a peripheral stimulator should be easily available (PNS-zones) were identified. 
These areas consisted of 48 operating theatre or procedural areas (e.g. Catheterisation laboratory, 
Electroconvulsive therapy suite) and 11 recovery areas. 
Of these areas, 37 PNS-zones were deemed to meet the PNS availability criteria suggested in the SASA 
guidelines. When looking at the data in more detail, one would see that a PNS unit was found to be 
physically present in 21 areas, easily available in 19 areas and not easily available in 19 areas. Three 
areas were found with dysfunctional PNS, resulting in them being classified as available but not meeting 
the overall availability standard. 
PNS units are often shared between operating theatres to save costs. Therefore it is important to define 
adequate availability. For the purpose of this study, importance was placed on having a “designated 
specific location” for the device. If the device was kept in a specifically labelled location just outside 
theatre, it would be labelled as adequately available. On the other hand, if a unit was shared between 
theatres but was not kept in a designated location it was deemed “not easily available”. 
TOF-ratio display capability was only represented in 14 of the units. Of these 14 units only 8 were fully 
functional. (See Figure 2) 
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Figure 2: Summary of Audit results 
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65 PNS units were tested for functionality. The different makes and models are depicted in the chart 
below (figure 3). Of these units, 39 were deemed to be dysfunctional and the remaining 26 units were 
deemed fully functional. 
 
 
Figure 3: PNS makes and models encountered 
 
 
The faults found with the units were as follow: 
- Absence of electrode cables was found in 27 units. These cables were either lost during clinical 
use or discarded by technicians when found to be malfunctioning. Given that many of the units 
were no longer manufactured or supported by their manufacturers, replacement cables could 
not be acquired. Only 3 units were found to have faulty cables, but it may well be the most 
frequent malfunction found on the PNS, given that a large number of the “missing” cables may 
reflect original cable malfunction. 
- The other malfunctions found are indicated in figure 4 below. 
 
 
Figure 4: Faults found with PNS units 
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The overall consistency of the delivered voltage spikes is noteworthy. In total 61 units were able to give 
scope meter recordings, although this was often performed with a set of “loan cables” where the units’ 
original cables were damaged or missing. This translated into 244 peak values for TOF voltage peak 
measurements. An assessment was made of the mean and standard deviation of the peak values 
measured with the scope meter. The skewness and kurtosis suggested normal distribution of the data 
and there was no sign change from baseline readings with paired t-tests. 
 
 
Discussion: 
 
The ability to monitor neuromuscular blockade is considered essential and is a minimum requirement 
for providing anaesthesia and perioperative care according to the 2012 SASA guidelines. 
This audit revealed that there were not enough functional PNS available at the institution. There were 
8 functioning TOF-R capable peripheral nerve stimulators available to cover 59 areas. If we add the 
handheld devices without TOF-Ratio capability, 37 areas out of the 59 (63%) are covered. This were in 
keeping with the author’s experience of PNS availability while working in clinical practice at this 
institution, where it was often difficult to locate a PNS at short notice. 
It can be inferred that it is unlikely that peripheral neuromuscular blockade monitoring is performed to 
the current accepted standard of a “TOF-Ratio of >0.9” if we have only 8 such devices available to 
cover 59 PNS zones at our institution. 
The clinical significance of the shortage of PNS units vary depending on the actual need for PNMB 
monitoring in the area concerned. Despite this, the SASA practice guidelines do not make concessions 
for areas where PNS are less likely to be used and describe this as an essential monitor that needs to be 
immediately available. Thus, a lower likelihood of needing the device should not be used as an excuse 
for inadequate coverage. 
The logistics of tracking a PNS unit’s location is very important in situations where nerve stimulators 
have to be shared between locations. In areas where the nerve stimulator may be used in more than 2 
locations, immediate availability of the device is lost once it is in use. In order to facilitate locating the 
device the unit has to be stored in a specific named “base” location, and the whereabouts of the device 
must be documented once it is removed. This could be done with the use of a simple notebook kept at 
the “base location”, or by online systems such as a “device-location-Whatsapp-group” shared between 
users of the device. 
From a technical point of view the working PNS were found to be very consistent in their delivered 
current bursts. This information is useful when troubleshooting a PNS unit. Looking at our data set there 
would be a high likelihood of the electrode cable being the problem rather that the rest of the electronic 
hardware. 
Another possible relevant factor that was not explored in this study is the likelihood of skin resistance 
contributing to measurement variance. Skin resistance may vary with skin thickness, moisture content 
and temporal association with prior electrical stimulation. It has also been known for a long time that 
skin impedance decreases when exposed to higher intensity currents. 29 
There are problems with the older PNS units, which comprise the majority of units in the institution: 
 
- The inability of these devices to exclude incomplete return of neuromuscular function by 
modern standards make them all but obsolete. However, some value remains in the ability to 
demonstrate very deep NMB levels were fade is detectable clinically and to demonstrate where 
TOF counts less than 4 are present. 
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- The lack of manufacturer support for many of the older PNS units in use at our institution 
shortens the foreseeable lifespan of the remaining functional PNS fleet. Some of these PNS 
models are no longer manufactured. Most of these units will thus become unusable at some 
point when they break down and need maintenance or repairs. 
 
Implications for our region from the audit findings 
 
- The performance of this audit helped catalyse the acquisition of further modern PNS 
units at our institution. At the time of this write-up a further 8 E-NMT units have already 
been delivered to GSH hospital and the plan is to continue building our fleet for the 
future. 
 
- Procurement of a modern scope meter with the ability to store and download test data 
in a downloadable format should be considered for the clinical engineering departments 
of the hospitals where PNS are used. This equipment will facilitate routine maintenance 
and enable future audit projects of electronic devices. 
 
- Hospitals needs to continue acquiring more TOF-R capable units to align themselves 
with measurement standards described in the literature. 
 
- An awareness and educational campaign needs to be launched within the departments 
of anaesthesia to educate and motivate anaesthetists to: 
 
o Utilise appropriate PNMB monitoring, and 
o Advocate for the provision of adequate numbers of PNS devices. 
 
- The cost and availability of repairs and cable replacements should be factored into the 
decision when acquiring more PNS units. The anaesthetic machine mounted PNS unit 
retail for about 3 times the price of the handheld device. It is hypothesized that the 
machine mounted units may last longer due to: 
o Higher quality electrode cabling 
o Less handling of the machine mounted units, resulting in 
 A smaller chance of being dropped and broken 
 Less winding up / coiling of the electrode cables which may prolong 
cable life. 
 
- The cost-benefit ratio of the current options (E-NMT vs. Xavant Stimpod NMS450) 
should be further audited prospectively while in use to help guide future acquisitions of 
these devices. 
 
- There may be a potential market for small cost-effective skin-equivalent resistance test- 
circuit devices that can give a binary confirmation of functionality for a PNS unit 
delivering TOF and DBS. 
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Summary 
 
- Patients should have their neuromuscular function monitored perioperatively during and after 
the administration of neuromuscular blocking agents until full return of neuromuscular 
function. 
- The practical “standard of care” for neuromuscular function monitoring is the use of 
acceleromyography in conjunction with device software that will express a Train-of-four ratio. 
30 
- This audit highlighted the need at the author’s institution for more new generation PNS with 
TOF-ratio-display-ability to align ourselves with the recommendations from the anaesthetic 
literature. 
- It also highlighted the need for an improved sharing system in those areas were PNS: clinical 
area ratio is <1. 
- This research also highlighted the accuracy and consistency of delivered current bursts by the 
working PNS devices. 
- There are opportunities for further research in evaluating the contribution of skin related factors 
on the conduction of current bursts with PNS. 
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PART D - APPENDICES 
 
Glossary of terms used (article): 
 
DBS - Double Burst Stimulation 
NMB - Neuromuscular blockade 
PACU – Post anaesthesia care unit 
PNS -Peripheral nerve stimulators 
PNS-zones – Areas where Peripheral stimulator availability is needed according to South African 
Society for Anaesthesiologists’ practice guidelines. 
PNM – Peripheral neuromuscular monitors (a synonym for PNS) 
PORC – Post-operative residual curarization. 
POPC - Post-operative pulmonary complications 
RCWMCH – Red Cross War Memorial Children’s Hospital 
RNMB - Residual neuromuscular blockade, a synonym for PORC 
SASA - South African Society of Anaesthesiologists 
TOF - Train-of-Four peripheral nerve stimulator mode. 
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Francis please visit our Author Services website. 
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Abstract 
All articles should include an abstract. The structured abstract for an Original Research article should 
be between 200 and 230 words and should consist of four paragraphs labelled Background, Methods, 
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how the study was performed, the major results, and what the authors conclude from these results. 
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Keywords 
All articles should include keywords. Up to five words or short phrases should be used. Use terms from 
the Medical Subject Headings (MeSH) of Index Medicus when available and appropriate. Key words 
are used to index the article and may be published with the abstract. 
 
Acknowledgements 
In a separate section, acknowledge any financial support received or possible conflict of interest. This 
section may also be used to acknowledge substantial contributions to the research or preparation of 
the manuscript made by persons other than the authors. 
 
References 
Cite references in numerical order in the text, in superscript format (Format> Font> Click superscript). 
Please do not use brackets or do not use the foot note function of MS Word. 
 
In the References section, references must be typed double-spaced and numbered consecutively in 
the order in which they are cited, not alphabetically. 
 
The style for references should follow the format set forth in the Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals (http://www.icmje.org) prepared by the International 
Committee of Medical Journal Editors. Abbreviations for journal titles should  follow  “Index  Medicus 
format. Authors are responsible for the accuracy of all references. Personal communications and 
unpublished data should not be referenced. If essential, such material should be incorporated in the 
appropriate place in the text. 
 
List all authors when there are six or fewer; when there are seven or more, list the first three, then 
";et al."; When citing URLs to web documents, place in the reference list, and use the following format: 
Authors of document (if available). Title of document (if available). URL. (Accessed [date]). 
 
The following are sample references: 
 
1. Jun BC, Song SW, Park CS, Lee DH, Cho KJ, Cho JH. The analysis of maxillary sinus aeration 
according to aging process: volume assessment by 3-dimensional reconstruction by high- 
resolutional CT scanning. Otolaryngol Head Neck Surg. 2005 Mar; 132(3):429-34. 
2. 2. Polgreen PM, Diekema DJ, Vandeberg J, Wiblin RT, Chen YY, David S, et al. Risk factors for 
groin wound infection after femoral artery catheterization: a case-control study. Infect 
Control Hosp Epidemiol [Internet]. 2006 Jan [cited 2007 Jan 5];27(1):34-7. Available from: 
http://www.journals.uchicago.edu/ICHE/journal/issues/v27n1/2004069/2004069.web.pdf. 
 
More sample references can be found at: http://www.nlm.nih.gov/bsd/uniform_requirements.html 
55 | P a g e  
Tables 
Tables should be self-explanatory, clearly organised, and supplemental to the text of the manuscript. 
Each table should include a clear descriptive title on top and numbered in Roman numerals (I, II, etc) 
in order of its appearance as called out in text. Tables must me inserted in the correct position in the 
text. Authors should place explanatory matter in footnotes, not in the heading. Explain in footnotes 
all non-standard abbreviations. 
 
For footnotes use the following symbols, in sequence:*,†,‡,§,||,**,††,‡‡ 
 
Figures 
All figures must be inserted in the appropriate position of the electronic document. Symbols, lettering, 
and numbering (in Arabic numerals e.g. 1, 2, etc. in order of appearance in the text) should be placed 
below the figure, clear and large enough to remain legible after the figure has been reduced. Figures 
must have clear descriptive titles. 
 
Photographs and images 
If photographs of patients are used, either the subject should not be identifiable or use of the picture 
should be authorised by an enclosed written permission from the subject. The position of photographs 
and images should be clearly indicated in the text. Electronic images should be saved as either jpeg or 
gif files. All photographs should be scanned at a high resolution (300dpi, print optimised). Please 
number the images appropriately. 
 
Permission 
Permission should be obtained from the author and publisher for the use of quotes, illustrations, 
tables, and other materials taken from previously published works, which are not in the public domain. 
The author is responsible for the payment of any copyright fee(s) if these have not been waived. The 
letters of permission should accompany the manuscript. The original source(s) should be mentioned 
in the figure legend or as a footnote to a table. 
 
Review and action 
 
Manuscripts are initially examined by the editorial staff and are usually sent to independent reviewers 
who are not informed of the identity of the author(s). When publication in its original form is not 
recommended, the reviewers' comments (without the identity of the reviewer being disclosed) may 
be passed to the first author and may include suggested revisions. Manuscripts not approved for 
publication will not be returned. 
 
Ethical considerations 
Papers based on original research must adhere to the Declaration of Helsinki on "Ethical Principles 
for Medical Research Involving Human Subjects"; and must specify from which recognised ethics 
committee approval for the research was obtained. 
 
Conflict of interest 
 
Authors must declare all financial contributions to their work or other forms of conflict of interest, 
which may prevent them from executing and publishing unbiased research. [Conflict of interest exists 
when an author (or the author's institution), has financial or personal relationships with other persons 
or organizations that inappropriately influence (bias) his or her opinions or actions.]* *Modified from: 
Davidoff F, et al. Sponsorship, Authorship, and Accountability. (Editorial) JAMA 2001: 286(10) The 
following declaration may be used if appropriate: "I declare that I have no financial or personal 
relationship(s) which may have inappropriately influenced me in writing this paper." 
56 | P a g e  
Submissions and correspondence 
All submissions must be made online at http://www.editorialmanager.com/sajaa and correspondence 
regarding manuscripts should be addressed to: 
 
The Editor, SAJAA, E-mail: toc@sajaa.co.za 
 
Note: Ensure that the article ID [reference] number is included in the subject of your email 
correspondence. 
 
Electronic submissions by post or via email 
Authors with no e-mail or internet connection can mail their submissions on a CD to: SAJAA, PO Box 
14804, Lyttelton Manor, 0140, Gauteng, South Africa. 
 
All manuscripts will be processed online. 
 
 
Article Publishing Charges 
The South African Society of Anaesthesiologists is currently covering all APCs and authors will not be 
charged. 
